This is a Validated Antibody Database (VAD) review about Rhesus mon.. CD81, based on 6 published articles (read how Labome selects the articles), using CD81 antibody in all methods. It is aimed to help Labome visitors find the most suited CD81 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD81 synonym: CD81 antigen

BioLegend
mouse monoclonal (5A6)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD81 antibody (BioLegend, 349502) was used in flow cytometry on human samples (fig 1c). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (5A6)
  • flow cytometry; human; fig 6
BioLegend CD81 antibody (BioLegend, 349510) was used in flow cytometry on human samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (5A6)
  • western blot; human; 1:50; loading ...; fig s4c
BioLegend CD81 antibody (BioLegend, 349502) was used in western blot on human samples at 1:50 (fig s4c). Oncotarget (2015) ncbi
mouse monoclonal (5A6)
  • immunocytochemistry; human; 10 ug/ml
  • western blot; human; fig 1f
In order to determine the role of CD9 in adhesion, migration and invasiveness of breast cancer cells, BioLegend CD81 antibody (BioLegend, 349502) was used in immunocytochemistry on human samples at 10 ug/ml and in western blot on human samples (fig 1f). Oncotarget (2015) ncbi
mouse monoclonal (5A6)
  • immunocytochemistry; human; 1:100
BioLegend CD81 antibody (BioLegend, 5A6) was used in immunocytochemistry on human samples at 1:100. J Biol Chem (2014) ncbi
mouse monoclonal (5A6)
  • immunocytochemistry; human
In order to identify the relationship between the nuclear tetraspanin-29 pool and the mitotic process, BioLegend CD81 antibody (Biolegend, 349502) was used in immunocytochemistry on human samples . Mol Cancer Res (2014) ncbi
Articles Reviewed
  1. Knickelbein J, Liu B, Arakelyan A, Zicari S, Hannes S, Chen P, et al. Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium. Invest Ophthalmol Vis Sci. 2016;57:4101-7 pubmed publisher
  2. Angeloni N, McMahon K, Swaminathan S, Plebanek M, Osman I, Volpert O, et al. Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1. Sci Rep. 2016;6:22915 pubmed publisher
  3. Rodríguez M, Silva J, Herrera A, Herrera M, Peña C, Martín P, et al. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer. Oncotarget. 2015;6:40575-87 pubmed publisher
  4. Rappa G, Green T, Karbanová J, Corbeil D, Lorico A. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015;6:7970-91 pubmed
  5. Liang Y, Eng W, Colquhoun D, Dinglasan R, Graham D, Mahal L. Complex N-linked glycans serve as a determinant for exosome/microvesicle cargo recruitment. J Biol Chem. 2014;289:32526-37 pubmed publisher
  6. Rappa G, Green T, Lorico A. The nuclear pool of tetraspanin CD9 contributes to mitotic processes in human breast carcinoma. Mol Cancer Res. 2014;12:1840-50 pubmed publisher